Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single- center experience

Annals of Surgery

Volumn 229, Issue 6, 1999, Pages 824-833

  Ghobrial, Rafik M ^a   Farmer, Douglas G ^a   Baquerizo, Angeles ^a   Colquhoun, Steven ^a   Rosen, Hugo R ^a   Yersiz, Hasan ^a   Markmann, James F ^a   Drazan, Kenneth E ^a   Holt, Curtis ^a   Imagawa, David ^a   Goldstein, Leonard I ^a   Martin, Paul ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; PREDNISONE; TACROLIMUS;

CAUSE OF DEATH; CONFERENCE PAPER; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; CYCLOSPORINE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033510546     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199906000-00009     Document Type: Conference Paper

References (35)

1. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26(suppl 1):62S-65S.
2. Wright TL. Liver transplantation in patients with chronic hepatitis B and C. In Maddrey WC, Sorrell MF, eds. Transplantation of the liver, 2d ed. Norwalk, CT: Appleton and Lange; 1995:477.
3. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997; 26:43S.
4. Feray C, Samuel D, Thiers V, et al. Reinfection of liver grafts by hepatitis C virus after liver transplantation. J Clin Invest 1992; 89: 1361-1365.
5. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994-999.
6. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103:317-322.
7. Rosen H, Gretch DR, Oehlke M, et al. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998; 65:1178-1182.
8. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzal TE. Orthotopic liver transplantation for hepatitis B virus-related liver disease. Hepatology 1991; 13:619-626.
9. Fishman JA, Rubin RH, Koziel MJ, Periera BJ, Hepatitis C virus and organ transplantation. Transplantation 1996; 62:147-154.
10. Sorrell MF. Hepatitis C recurrence after liver transplantation: is there cause for concern? Am J Gastroenterol 1997; 92:1416-1417.
11. Crippin J, Foster B, Carlen S, Bereich A, Bodenheimer H. Retransplantation in hepatitis B: a multicenter experience. Transplantation 1994; 57:823-826.
12. Rosen HR, Shackleton CR, Higa L, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997; 92:1453-1457.
13. Singh N, Gayowski T, Ndimbie OK, Nedjar S, Wagener MM, Yu VL. Recurrent hepatitis C virus in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. Surgery 1996; 119:452-456.
14. Sheiner PA, Schwartz ME, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21:30-34.
15. Herrero JI, De La Pena A, Quiroga J, et al. Risk factors for recurrence of hepatitis C after liver transplantation. Liver Transpl Surg 1998; 4:265-270.
16. Freeman RB, Tran S, Lee YM, Rohrer RJ, Kaplan MM. Serum hepatitis C RNA titer after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 1996; 61:542-546.
17. Ghobrial RM, Colquhoun S, Rosen H, et al. Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. Transplant Proc 1998; 30:1470-1471.
18. Fabrizi F, Martin P, Dixit V, et al. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. Am J Kidney Dis 1998; 31:647-654.
19. Boker KHW, Dalley G, Bahr MJ, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203-210.
20. Casavilla FA, Rakela J, Kapur S, et al. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transplant Surg 1998; 4:448-454.
21. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Eng J Med 1996; 334:815-820.
22. Gane EJ, Naoumov NV, Qian KP, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110:167-177.
23. Schluger LK, Sheiner PA, Thung SN, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23:971-976.
24. Casavilla A, Mateo R, Rakela J, Irish W, Demetris AJ, Starzal TE. Impact of hepatitis C viral infection on survival following primary liver transplantation under FK [abstract]. Hepatology 1994; 20:133A.
25. Feray C, Habsanne A, Samuel D, Farges O, Reynes M, Bismuth H. Poor prognosis of patients retransplanted for hepatitis C virus. Hepatology 1995; 22:135A.
26. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331:1110-1115.
27. Casavilla FA, Lee R, Lim J, et al. Outcome of liver retransplantation for recurrent hepatitis C infection. Hepatology 1995; 22:153A.
28. Rosen H, Martin P. Hepatitis C infection in patients undergoing liver transplantation. Transplantation 1998; 66:1612.
29. Markmann JF, Markowitz JS, Yersiz H, et al. Long-term survival after retransplantation of the liver. Ann Surg 1997; 226:408-420.
30. Wong T, Devlin J, Roland N, et al. Clinical characteristics affecting the outcome of liver retransplantation. Transplantation 1997; 64:878-882.
31. Sheiner PA, Schluger LK, Emre S, et al. Retransplantation for hepatitis C. Liver Transpl Surg 1997; 3:130-136.
32. Doyle HR, Morelli F, McMichael J, et al. Hepatic retransplantation - an analysis of risk factors associated with outcome. Transplantation 1996; 61:1499-1505.
33. Rosen HR, O'Reilly PM, Shackleton CR, et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62:1773-1776.
34. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28:823-830.
35. Singh N, Gayowski T, Wagner MM, Marino IR. Increase infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996; 61:402-406.